The shares of American Tower Corporation (AMT) generated a string of transactions, indicating high demand among diverse financial institutions despite a dip in its stock value in Q4. Bullish moves were seen across the bio-tech sector with several entities like First Financial Bankshares Inc, Alliancebernstein L.P., Harber Asset Management LLC, and the Royal Bank of Canada adding to their AMT stakes. Simultaneously, certain holdings sold AMT shares, such as DoubleLine ETF Adviser LP and EP Wealth Advisors LLC.
Most brokerages rated AMT a moderate buy. The company exceeded Q2 expectations, leading to raised guidance on 5G rollout and currency gains. Despite being in a legal dispute with AT&T Mexico, the firm recorded 11.2% YTD rise in stocks. OMERS ADMINISTRATION Corp and others reduced position, despite the company's robust performance.
AMT's leadership has seen notable changes, including the election of Gene Reilly to Board of Directors. In addition, the company will be presenting at upcoming September conferences.
American Tower Corporation AMT News Analytics from Tue, 28 Jan 2025 08:00:00 GMT to Sat, 06 Sep 2025 13:34:56 GMT - Rating 8 - Innovation -3 - Information 7 - Rumor -5
